Financing
Net change in commercial paper
Year-over-year, this metric grew by 100.0%, from -$2.69B to $0.00.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2016
Last reportedQ3 2025
How to read this metric
Increased reliance on commercial paper may signal tight cash flow or seasonal working capital needs.
Detailed definition
This represents the net change in short-term unsecured debt obligations issued by the company to meet immediate working...
Peer comparison
Standard for large-cap companies with high credit ratings and active treasury operations.
Metric ID:
cf_commercial_paper_netHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.99B | $2.70B | -$2.69B | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | — | — | — | — | — | -9.6% | -199.5% | +100.0% | — | — | — |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | -100.0% | -100.0% | +100.0% |
Range-$2.69B – $2.99B
Avg YoY Growth-33.3%
Median YoY Growth-100.0%
Net change in commercial paper at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's net change in commercial paper?
- Bristol-Myers Squibb (BMY) reported net change in commercial paper of $0.00 in Q3 2025.
- How has Bristol-Myers Squibb's net change in commercial paper changed year-over-year?
- Bristol-Myers Squibb's net change in commercial paper increased by 100.0% year-over-year, from -$2.69B to $0.00.
- What does net change in commercial paper mean?
- The net increase or decrease in short-term debt issued to fund operations.